The Francis Crick Institute
Browse

Recent advances in metal complexes for antimicrobial photodynamic therapy.

Download (4.79 MB)
journal contribution
posted on 2023-08-17, 10:16 authored by Thomas W Rees, Po-Yu Ho, Jeannine Hess
Antimicrobial resistance (AMR) is a growing global problem with more than 1 million deaths due to AMR infection in 2019 alone. New and innovative therapeutics are required to overcome this challenge. Antimicrobial photodynamic therapy (aPDT) is a rapidly growing area of research poised to provide much needed help in the fight against AMR. aPDT works by administering a photosensitizer (PS), which is activated only when irradiated with light, allowing high spatiotemporal control and selectivity. The PS typically generates reactive oxygen species (ROS), which can damage a variety of key biological targets, potentially circumventing existing resistance mechanisms. Metal complexes are well known to display excellent optoelectronic properties and recent focus has begun to shift towards their application in tackling microbial infections. We herein review the last 5 years of progress in the emerging field of small molecule metal complex PSs for aPDT.

Funding

Crick (Grant ID: CC2215, Grant title: Hess CC2215)

History